This website aims to educate the public about the importance of Human Epidermal Growth Factor Receptor 2 (HER2) in breast cancer and its implications in disease management. A brief overview of the breast cancer types will be provided and a comprehensive discussion is performed on the topic of biosimilars, particularly Trastuzumab due to its usage as a treatment option for breast cancer.